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Abstract The National Center for Biotechnology In-
formation (NCBI) organizes information resources for
life scientists on an evolutionary scheme. This facil-
itates research about present-day organisms. The re-
cent discovery of a new arenavirus, the LUJO virus,
illustrates the utility of adopting evolution as a central
architectural principle for life sciences databases: using
the NCBI’s resources, clinicians were able to classify
the new virus in real time—soon enough to aid in the
diagnosis and treatment of a hemorrhagic fever caused
by the LUJO virus. Topics fundamental to the study of
evolution, often thought of as useless, are indeed vital
because they inform how life science information ought
to be organized.
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Introduction
The National Center for Biotechnology Information
(NCBI), part of the U.S. National Library of Medicine,
is responsible for a suite of databases, at http://www.
ncbi.nlm.nih.gov/, which it maintains and continues to
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develop. These databases, available worldwide free of
charge and requiring no authentication by password or
any other registration, are among the most important
information resources used by researchers: they con-
tain records for a significant proportion of the world’s
literature and data in the life sciences. In accord with
the famous statement “nothing makes sense except in
light of evolution” (Dobzhansky 1973), the manner in
which the NCBI organizes information about the living
world reflects the organization, by lines of descent, of
the living world itself.
In this paper, I illustrate the power of organizing
information this way. I report on recent research in epi-
demiology and clinical medicine: using gene sequenc-
ing technology, the NCBI’s information resources, and
exceptional scientific sleuthing skills, an international
team has developed a method to identify a previously
unknown pathogen rapidly enough to influence deci-
sions about medical treatment and measures to protect
public health almost as soon as an infected individual’s
symptoms first appear.
An Unexplained Outbreak of Hemorrhagic Fever
Paweska et al. (2009) describe the case of a patient
who contracted and died of an illness which could not
be identified at the time of her death. Near Lusaka,
Zambia, the patient first suffered chills and digestive
symptoms and was treated for food poisoning and flu.
New symptoms arose: chest pain, sore throat, and fever;
a head-to-toe rash; facial swelling; and myalgia (muscle
pain). The patient visited a local clinic, where these
new symptoms were attributed to an allergic reaction
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to one of the drugs she was taking to treat her ear-
lier symptoms. She was discharged but returned later
the same day and was moved to a local hospital. She
was subsequently airlifted to another in Johannesburg,
South Africa. In Johannesburg, physicians found the
patient unresponsive to light stimuli and to be suffering
from acute respiratory distress syndrome, kidney fail-
ure, serious blood pathology, and a cerebral edema; an
eschar (scab), believed to be a result of rickettsiosis,
appeared on her foot. Despite aggressive treatment in
Johannesburg for likely causes of her illness, the patient
died within approximately two weeks of the onset of
her symptoms in Lusaka, approximately four days after
her admission to the Johannesburg hospital.
In the course of her transport to Johannesburg and
her treatment there, three other individuals who had
come into contact with the Lusaka patient or with
one another became violently ill and died within ap-
proximately two weeks of their initial contact with an
infected individual. A fourth new patient, the fifth if
the Lusaka patient is counted, was also infected. In
retrospect, after the death of the third newly infected
patient, physicians identified the illness as hemorrhagic
fever, a disease characterized by a broad spectrum of
symptoms including those suffered by the Lusaka pa-
tient. The hemorrhagic fevers are divided into classes.
What determines whether a given person’s hemor-
rhagic fever falls into one class or another depends on
what type of pathogen caused it, its locale, and its usual
host—mouse, mosquito, or chicken, for example. There
are four taxa of viruses responsible for the variety of
hemorrhagic fevers, including the filioviruses, which
include two of the most notorious viruses, Marburg and
Ebola (CDC, Special Pathogens Branch 2010; National
Library of Medicine, USA 2010b). Taking previous
cases as a guide, a reasonable person would be justified
in estimating the fifth patient’s life expectancy at two
weeks from the time her symptoms began.
Pathologists at the National Institute for Communi-
cable Diseases (NICD) of South Africa tested samples
from infected patients using a technique known as
reverse-transcriptase polymerase chain reaction (RT-
PCR). The polymerase chain reaction will create many,
many copies of DNA genes from a sample containing
only a few. This makes it possible to detect and study
DNA from the sample, even if it contains a small
amount of DNA. Reverse transcriptase PCR is similar.
Arenaviruses use RNA as their hereditary material;
RT-PCR creates a DNA template corresponding to
viral RNA genes. This reverses the process of tran-
scription that, in organisms using DNA as their primary
genetic material, transcription creates a strand of RNA
corresponding to the DNA genes; this RNA carries
the information encoded in the DNA forward into the
process of protein synthesis. The results of the NICD’s
RT-PCR tests were negative for hemorrhagic fever.
In the meantime, tissue and blood samples were
sent to the United States’ Special Pathogens Branch
of the Centers for Disease Control (CDC), in Atlanta,
Georgia. There, immunohistochemical testing was per-
formed. In an immunohistochemical test, a sample from
the patient is treated with antibodies known to react
with the suspected pathogen; if the reaction occurs, a
stain applied to the sample will take on a distinctive
color. Of course, if nothing is known about the likely
pathogen, no antibodies can be designed for the test.
Not having ruled out the arenaviruses, the CDC tested
for them using antibodies that would react with a range
of arenaviruses known to cause hemorrhagic fever.
The test was positive and physicians in Johannesburg
started treating the patient with ribavirin, an antiviral
drug. The NICD sent tissue and blood samples to At-
lanta on 9 October 2008; the samples were received
in Atlanta on 10 October, and the CDC reported the
results of its immunohistochemical assay on 11 Octo-
ber; the ribavirin treatment began on that same day.
By 2 December, the patient had recovered from hemor-
rhagic fever; tests for viral RNA in the patient’s blood
and urine were negative.
The achievement of the medical personnel and sci-
entists in Zambia, South Africa and the United States
is impressive. Their first patient died for no reason
anyone could discern at the time, and her illness was
transmitted to four others, three of whom died in a
similarly mysterious manner. A fifth patient contracted
the illness and faced near certainty of deterioration
and suffering followed by death within two weeks’
time. As it happened, however, the transatlantic col-
laboration learned enough about the pathogen within
36 hours of the patient’s admission to confidently rec-
ommend a therapy, which led to the patient’s complete
recovery.
A New Species of Arenavirus
Except in particularly clear cases, a distinction be-
tween clinical medicine, public health measures, and
pure research in biology and epidemiology cannot be
drawn. The events connected with the Lusaka pa-
tient exemplify this close interrelationship. Recall that
the NICD had conducted RT-PCR tests on the sam-
ples from the infected individuals but found nothing.
The CDC repeated these tests and found evidence of
arenavirus. The immunohistochemical tests conducted
by the CDC were conclusive enough to warrant treating
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the patient with ribavirin; the RT-PCR tests, conducted
at the same time, confirmed the immunohistochem-
ical results. Moreover, the RT-PCR tests led to im-
portant results in the genetics and taxonomy of the
Arenaviridæ. The NCBI’s evolutionary framework for
organizing information is essential to these kinds of
discoveries.
As I described above, RT-PCR creates DNA tem-
plates corresponding to viral RNA, copying them
many, many times, so that even if there is only a small
number of genes in a sample, they can be detected and
isolated for study. In some cases, in which the genes
of interest are known, the purpose of RT-PCR is to
obtain more copies of them to study their properties.
In this case, the virus’ genes were not known, and the
purpose of the RT-PCR test was to aid in their iden-
tification. In short, if enough genes can be identified,
their order can be determined, and longer stretches can
be constructed. These longer stretches are then tested
for matches against a library of gene sequences from
organisms whose genetic makeup is already known.
To match gene sequences with one another, scien-
tists use an NCBI digital tool called the Basic Local
Alignment Search Tool (BLAST). The researcher en-
ters the gene sequence in which he or she is inter-
ested into the BLAST system, often by simply cutting
and pasting it into a text entry box on the BLAST
web site. This gene sequence is then compared by the
BLAST program to the gene sequences in the NCBI’s
databases. These databases are themselves remarkable.
When scientists identify a gene sequence, they submit
it online to the NCBI, which provides access to it by
way of a range of research tools, including BLAST.
This exemplifies the idea that science is a collective
enterprise; members of the scientific community have
submitted enough gene sequences to construct 2,467
viral genomes.
If there is a very small probability that the se-
quence under study would be identical to a sequence
in the database by chance, the two are considered
a match. In the Lusaka virus case, the immunohis-
tochemical staining indicated the presence of an are-
navirus, but did not indicate one or another species.
The BLAST system indicated that the gene sequences
detected by the CDC’s RT-PCR match “approximately
50% of a prototypic arenavirus genome” (Briese et al.
2009a). This is strong evidence that the unidentified
virus is indeed a species of the Arenaviridæ. A phy-
lum becomes more diverse—i.e., new species form—
when a group of organisms in an already-existing
species separates from others in the species and, with
time, changes significantly enough to differ in kind
from its former conspecifics. Scientists disagree about
what biological changes are necessary before two
diverging populations separate enough to be consid-
ered different species, although many agree that re-
productive isolation is sufficient. Divergence is never
total, however: related species share a considerable
portion of their genomes, a legacy of their shared
past.
The logic of the BLAST tool is the same that a
professor might use to identify a plagiarized term pa-
per. Suppose that a term paper contains the phrase
“LCMV infection is only rarely fatal in immunocompe-
tent adults; however, infection during pregnancy bears
serious risks for mother and child and frequently results
in congenital abnormalities.” Suspecting that a student
would not write this sentence, the professor searches
the Internet for “LCMV infection is only rarely fatal
in immunocompetent adults; however,” the first part
of the suspicious passage. It appears only once online,
in the paper cited above (Briese et al. 2009a) about
the Lusaka arenavirus. On one hypothesis, the passage
from the article and the term paper match because
the student used the same words to express ideas he
or she shares with the scientists but did so indepen-
dently. This is highly improbable. On a contrasting
hypothesis, the passages match because they share a
common history: Briese and colleagues expressed their
thoughts by writing the passage, and the student copied
the passage. This is clearly the stronger hypothesis.
If the two instances of the passage share this com-
mon history, it is highly probable that they would be
identical.
To complete the analogy, a viral gene sequence
submitted to BLAST is like the student paper; the
sequences in the BLAST database are like the Internet,
searched by the professor for the source of the student
paper. If the BLAST database contains a sequence S,
and S matches a viral DNA sequence that is highly
unlikely to have formed independently, it is returned
as a search result. This provides warrant for the belief
that the viral gene sequence and the sequence in the
BLAST database are historically related. The more
viral DNA that scientists can test against the BLAST
database and the larger the BLAST database, the more
reliable and more precise the results. As I mentioned
previously, the CDC determined that the Lusaka virus
and the “prototypic arenavirus genome” were a 50%
match, enough to safely presume that the Lusaka virus
is indeed an arenavirus. This took 72 hours.
Discovering that the previously unknown pathogen
is a previously unidentified arenavirus is an impor-
tant achievement and, as I have stressed, eminently
useful in real time for the clinician. Nonetheless, the
researchers in this case went further: They sequenced
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the entire genome of the new virus. Samples of the
NICD-CDC materials were sent to Columbia Univer-
sity in New York, where researchers pieced together
the otherwise-unaccounted-for genetic material using a
high-throughput gene sequencing apparatus—so called
because it can sequence a large number of genes in a
short time. Although the sequence of events is hard
to reconstruct from the published papers, it is clear
that the Columbia researchers began to sequence the
remainder of the new virus’ genome without delay as
soon as they received the samples, and most likely
finished in a matter of days. Now in possession of the
complete genome of the virus, epidemiologists went
from having no information whatever about a pathogen
and the illness it causes to having a broad base of
important taxonomic and genetic information about it.
These data were submitted to the NCBI’s databases.
Physicians, public health officials and researchers, and
scientists doing basic research can now check new un-
knowns against it. The new virus is named LUJO, in
recognition of its first known victims in Lusaka and
Johannesburg. Its genome can be found in the NCBI’s
Entrez Genome database with the classification key
txid649188[orgn] (Briese et al. 2009b).
The Importance of Comparative Studies
Knowledge of the LUJO virus’ genome puts scientists
in an excellent position to understand how the virus
works. What is its life cycle? How does it survive in
its usual hosts? How does it spread in host popula-
tions? By what means does it construct its viral “outer
shell,” which forms the compartment in which the viral
genetic material is stored before it is released into
host cells? What physiological processes in a human
being does it disrupt in order to cause hemorrhagic
fever? Contrary to what might seem obvious, these
questions are not ahistorical, and the information re-
sources used to explore them are organized to reflect
this.
To be clear, the kind of research required to under-
stand how the LUJO virus works makes use of present-
day, real-time experiment and observation. Nonetheless,
there is a comparative method fundamental to planning
experiments and deciding what observations are most
likely to be interesting and useful. The reason that plac-
ing the LUJO virus among the Arenaviridæ is so im-
portant is that taxonomic differences, as a rule, reflect
differences important to understanding how related or-
ganisms work. Take, for instance, any present-day pop-
ulation of LUJO virus. The ancestry of this population
can be traced back to some population in the parent
species—individuals that began the separation which
would become a permanent species difference. Some
changes that occurred during that time are due to nat-
ural selection, that is, the adaptation of the LUJO virus
to an environment different than that of its parent. Oth-
ers are purely historical, in the sense that they do not
result from natural selection, for instance, they make no
difference or very little difference to any functional as-
pect of the virus’s biology. Comparing the present-day
genome of the LUJO virus to related species or species
in other related phyla is a good technique for learning
about how the LUJO virus works. Suppose a certain
gene in the LUJO virus has a certain function: how
does that same gene differ in species sharing LUJO’s
ancestry? Accordingly, does the biology of the LUJO
virus differ from its ancestors in any ways tied to their
genetic differences?
The NCBI databases are organized in a way that
facilitates this kind of comparative study. Using the
NCBI Nucleotide database, a researcher can enter in
the identification code for a given gene as a search key
to find identical or similar genes across taxa. Similar
searches can be carried out for across-taxa compari-
son using other databases such as Online Mendelian
Inheritance in Man and Online Mendelian Inheritance
in Animals, Protein, Structure, PopSet, and Conserved
Domains, to name a few; these and others can be
accessed from the NCBI web portal (National Library
of Medicine, USA 2010a). With this comparative strat-
egy, researchers can learn what a given gene does in
a given taxon or set of taxa and, reasoning that it
probably does something similar in the taxon under
study, begin to see how genetic differences result in
biological differences. Often, a daughter species differs
from its parent species as a result of having adapted by
natural selection to a new environment. Having infor-
mation about what the structure and function (if any)
of genes in related species offers a starting point for
experiment and observation of a recently discovered
species.
Concluding Remarks
Answering apparently ahistorical questions in clin-
ical medicine and public health requires informa-
tion about biological taxonomy and, more generally,
about changes over time in genetics and the biologi-
cal changes that result in new species or historically
related populations within a species. Accordingly, the
NCBI organizes scientific literature and data in a way
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that reflects historical relationships at all levels of bi-
ological organization. By exploring NCBI databases,
a researcher is, in effect, exploring evolutionary re-
lationships among taxa, essential to drawing conclu-
sions about present-day organisms. Our understanding
of molecular biology and genetics is relatively young,
compared with the practice of organizing plants and
animals into kinds, one of humanity’s oldest and widely
pursued activities. Nothing makes sense in biology ex-
cept in light of evolution. An important part of the great
utility of the NCBI databases derives from the kinds
of discoveries in molecular biology about present-day
organisms that everyone recognizes enthusiastically as
great advances: new medicines; deeper understanding
of the connection between mind and body; insight into
our physiology and metabolism; and improved crops
and livestock. We would do well to show similar enthu-
siasm for what might seem at first to be useless studies
in quaint subjects such as natural history, paleontology,
biogeography, ecology, and experiments and observa-
tions of natural selection in guppies, finches, and snails
and other apparently uninteresting organisms.
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